No influence of intravenous ciprofloxacin on histamine release, complement activation, and blood clotting system.
Wingender
W
W
Institute of Clinical Pharmacology, Bayer AG, Pharma Research Center - 5600 Wuppertal, FRG.
Beermann
D
D
Konrad-Dalhoff
I
I
Loof
I
I
Eckert
P
P
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology; D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D003167:Complement Activation / Q000187:drug effects*; D005174:Factor XII / Q000378:metabolism; D006632:Histamine / Q000097:blood; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D006632:Histamine; D000990:Antithrombin III; D005174:Factor XII